Literature DB >> 15112071

Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.

M Bertin1, A Muller, X Bertrand, C Cornette, M Thouverez, D Talon.   

Abstract

To investigate the relationship between glycopeptide use and decreased susceptibility to teicoplanin in coagulase-negative staphylococci (CNS) isolates, data on teicoplanin susceptibility and glycopeptide use from existing microbiology laboratory and pharmacy databases were collected for the period between July 2000 and March 2001. Pooled data for the entire study period were first used to analyse associations. Univariate analysis showed that the incidence of CNS with decreased susceptibility to teicoplanin was significantly correlated with the use of glycopetides, particularly with vancomycin use. This association was confirmed by multivariate analysis. This study suggests that variations in antimicrobial resistance are related to variations in antimicrobial use in the model of CNS with decreased susceptibility to teicoplanin, thus confirming the usefulness of restricting antimicrobial prescribing as a means of controlling resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112071     DOI: 10.1007/s10096-004-1129-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas.

Authors:  R L White; L V Friedrich; L B Mihm; J A Bosso
Journal:  Clin Infect Dis       Date:  2000-07-14       Impact factor: 9.079

2.  Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.

Authors:  J H Sloos; J A van de Klundert; L Dijkshoorn; C P van Boven
Journal:  J Antimicrob Chemother       Date:  1998-12       Impact factor: 5.790

3.  Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals.

Authors:  N S Crowcroft; O Ronveaux; D L Monnet; R Mertens
Journal:  Infect Control Hosp Epidemiol       Date:  1999-01       Impact factor: 3.254

4.  Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.

Authors:  F W Goldstein; A Coutrot; A Sieffer; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

5.  Teicoplanin-resistant coagulase-negative staphylococcus.

Authors:  A C Grant; R W Lacey; A M Brownjohn; J H Turney
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

6.  Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

Authors:  S S Wong; P L Ho; P C Woo; K Y Yuen
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

7.  Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study.

Authors:  E Tacconelli; M Tumbarello; K G Donati; M Bettio; T Spanu; F Leone; L A Sechi; S Zanetti; G Fadda; R Cauda
Journal:  Clin Infect Dis       Date:  2001-10-05       Impact factor: 9.079

8.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

Review 9.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

10.  Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.

Authors:  F Biavasco; E Giovanetti; M P Montanari; R Lupidi; P E Varaldo
Journal:  J Antimicrob Chemother       Date:  1991-01       Impact factor: 5.790

View more
  3 in total

1.  Genetic analysis of glycopeptide-resistant Staphylococcus epidermidis strains from bone and joint infections.

Authors:  Julie Cremniter; Valérie Sivadon-Tardy; Charlotte Caulliez; Thomas Bauer; Raphaël Porcher; Alain Lortat-Jacob; Philippe Piriou; Thierry Judet; Philippe Aegerter; Jean-Louis Herrmann; Jean-Louis Gaillard; Martin Rottman
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

2.  Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades.

Authors:  E Ahlstrand; K Svensson; L Persson; U Tidefelt; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-05       Impact factor: 3.267

3.  Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.

Authors:  Cathy A Petti; Keith E Simmon; Jose M Miro; Bruno Hoen; Francesc Marco; Vivian H Chu; Eugene Athan; Suzana Bukovski; Emilio Bouza; Suzanne Bradley; Vance G Fowler; Efthymia Giannitsioti; David Gordon; Porl Reinbott; Tony Korman; Selwyn Lang; Cristina Garcia-de-la-Maria; Annibale Raglio; Arthur J Morris; Patrick Plesiat; Suzanne Ryan; Thanh Doco-Lecompte; Francesca Tripodi; Riccardo Utili; Dannah Wray; J Jeffrey Federspiel; K Boisson; L Barth Reller; David R Murdoch; Christopher W Woods
Journal:  J Clin Microbiol       Date:  2008-03-26       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.